SureTrader
Home > Boards > US OTC > Cannabis > Nemus Bioscience, Inc. (NMUS)

$4 a share would be a 440m market cap

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
AntonChigurh Member Profile
 
Followed By 2
Posts 457
Boards Moderated 0
Alias Born 04/03/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/21/2018 4:48:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/20/2018 6:30:50 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 2/13/2018 4:14:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/13/2018 4:09:08 PM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 1/30/2018 6:08:58 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/29/2018 5:42:46 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 1/25/2018 12:45:07 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/23/2018 5:45:38 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/23/2018 4:40:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/22/2018 5:26:38 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 1/22/2018 5:26:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/22/2018 5:25:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/22/2018 5:25:22 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/22/2018 4:36:22 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 1/3/2018 6:50:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/3/2018 6:47:40 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/5/2017 6:06:38 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 12/5/2017 6:04:04 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 11/22/2017 5:01:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2017 5:06:39 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/14/2017 4:53:12 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/14/2017 3:30:01 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/2/2017 6:14:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2017 6:14:33 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/13/2017 4:36:49 PM
AntonChigurh   Sunday, 09/24/17 12:22:02 AM
Re: cjarmstrong post# 2768
Post # of 4497 
$4 a share would be a 440m market cap

420m EV

With a fully funded Phase 1 trial of NB1222/NB1111 and then positive results, we would be Off to the races. Look at $ZYNE at its Peak , much higher

And Look at GW. SPent a Lot of time on their first drug that WILL NEVER get approved in the USA as a medicine. Maybe one day as a rec product. And now a new Drug in Phase 3 trials, when asked about the science of your manufacturing you give toss a word salad and conclude with 'sorry about unscientific answer', and now doubt about whether the benefit of CBD is directly from the molecule or an interaction with other epilepsy drugs.

Still 1B market cap.

I have them Right between the eyes, whether they know it or not

And I hope $ZYNE goes higher but some People are probably pretty mad at Management

I'm not short either and wish them Good luck


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist